CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Other events
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 3 Insider Initial Statement of Ownership
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Chief Executive Officer sold 2,403 shares at $0.78 ($1,874)
- 8-K Event Delisting notice
- 8-K/A Event Exhibits
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Patient Supply Officer sold 3,096 shares at $0.91 ($2,804)
- 4 Open-market sale Director sold 47,702 shares at $0.91 ($43,447)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 8 of 41 · 808 filings